Wilson Sonsini Goodrich & Rosati advised NiKang Therapeutics on the deal. NiKang Therapeutics, an early stage biotech company focused on developing novel small molecule oncology drug…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now